These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2391754)

  • 21. Treatment of bacterial enteritis.
    Nataro JP
    Pediatr Infect Dis J; 1998 May; 17(5):420-1. PubMed ID: 9613658
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experience of norfloxacin (Baccidal) in the urological field].
    Fukuoka H; Goto A; Sasaki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1667-74. PubMed ID: 4083223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical efficacy and safety of norfloxacin tablets in pediatrics].
    Morita H; Tomoda T; Araki K; Kurashige T; Nishibayashi Y; Matsumoto K; Zushi N
    Jpn J Antibiot; 1990 May; 43(5):884-9. PubMed ID: 2391760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
    Wang XF; Jiang SC; Wei YL
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):482-4, 511. PubMed ID: 2086018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Shimizu N; Tomizawa I; Takizawa Y; Nitia Y; Seo T; Kamimura M; Kanehisa N
    Kansenshogaku Zasshi; 1989 Jul; 63(7):659-75. PubMed ID: 2693543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of fosfomycin in Campylobacter jejuni enteritis].
    Fuchigami T; Ootaki A; Fujita Y; Yoza A; Ryo S; Nishiyama N
    Jpn J Antibiot; 1983 Oct; 36(10):2849-55. PubMed ID: 6674520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Campylobacter: common cause of enteritis in an infectious diseases hospital.
    Williams GV; Deacon GJ
    Med J Aust; 1980 Sep; 2(5):268-71. PubMed ID: 7432313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cephradine in the treatment of intestinal infections caused by Shigella or Salmonella organisms.
    Landa L
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):496-502. PubMed ID: 4629311
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
    Moolasart P; Eampokalap B; Ratanasrithong M
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):764-9. PubMed ID: 10928373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical observations with clarithromycin in pediatrics].
    Sekiguchi T; Okamoto T; Ohara K; Nishimori M; Kozan S; Miyazaki M
    Jpn J Antibiot; 1989 Feb; 42(2):411-9. PubMed ID: 2526254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Campylobacter infection in children].
    Behrens R; Kist M; Helwig H
    Immun Infekt; 1983 Mar; 11(2):55-60. PubMed ID: 6352463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial enteritis.
    Miller DP; Everett ED
    Mo Med; 1983 May; 80(5):241-8. PubMed ID: 6408371
    [No Abstract]   [Full Text] [Related]  

  • 35. [Netilmicin in the treatment of acute bacterial enteritis in childhood].
    Titone L; Dones P; Portelli V; Averna A
    Minerva Pediatr; 1984 Sep; 36(18):913-6. PubMed ID: 6394981
    [No Abstract]   [Full Text] [Related]  

  • 36. [In vitro antibacterial activity of norfloxacin (NFLX) against enteritis-causing bacteria].
    Goto N; Horiuchi S; Okamura N; Inagaki Y; Ozawa K; Mochizuki A; Nakaya R
    Kansenshogaku Zasshi; 1986 Apr; 60(4):315-21. PubMed ID: 3095460
    [No Abstract]   [Full Text] [Related]  

  • 37. Norfloxacin in the treatment of bacterial enteric infections.
    Ruiz-Palacios GM
    Scand J Infect Dis Suppl; 1986; 48():55-63. PubMed ID: 3535054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiologic and therapeutic study on gonococcal infections--clinical efficacy of norfloxacin].
    Sakai S; Kumamoto Y; Tsunekawa T; Hirose T; Tabata S; Gohro T; Inoke T; Igawa K; Tazuki J; Henmi I
    Hinyokika Kiyo; 1986 Nov; 32(11):1747-61. PubMed ID: 3825822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aspects of the etiology of enteritis in children].
    Coban V; Serban D; Ivanof A; Munteanu I; Ionescu N; Ciupe M; Prodan I; Lucaciu S; Dudea L; Oncu V
    Pediatria (Bucur); 1967; 16(6):481-7. PubMed ID: 4874932
    [No Abstract]   [Full Text] [Related]  

  • 40. Campylobacter enteritis.
    Blaser MJ; Reller LB
    N Engl J Med; 1981 Dec; 305(24):1444-52. PubMed ID: 7029281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.